Bain Capital Invests $419 Million in HeartFlow, Becoming Largest Institutional Holder

Bain Capital Life Sciences Investors has acquired a new position in HeartFlow, adding 12,448,158 shares valued at $419 million. This represents 27.81% of the fund's assets under management and makes HeartFlow its largest holding. HeartFlow is a medical technology company specializing in non-invasive diagnostics for coronary artery disease. The acquisition is notable, as it is a significant percentage of the company's market cap.